Alumis Inc. Files 8-K: Regulation FD & Financials
Ticker: ALMS · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Alumis Inc. (formerly Esker Therapeutics) filed an 8-K on 3/4/25 covering Reg FD and financials.
AI Summary
Alumis Inc. filed an 8-K on March 4, 2025, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing provides important updates on Alumis Inc.'s regulatory disclosures and financial reporting, which are crucial for investors to assess the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, primarily containing disclosures and exhibits, without immediate significant new financial or operational information.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, California (location) — Principal executive offices address
- March 4, 2025 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Alumis Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 4, 2025.
What was Alumis Inc.'s former company name?
Alumis Inc.'s former company name was Esker Therapeutics, Inc.
In which state is Alumis Inc. incorporated?
Alumis Inc. is incorporated in Delaware.
What is the address of Alumis Inc.'s principal executive offices?
The address of Alumis Inc.'s principal executive offices is 280 East Grand Avenue, South San Francisco, California 94080.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding ALUMIS INC. (ALMS).